1. Home
  2. INTS vs WVVI Comparison

INTS vs WVVI Comparison

Compare INTS & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • WVVI
  • Stock Information
  • Founded
  • INTS 2012
  • WVVI 1983
  • Country
  • INTS United States
  • WVVI United States
  • Employees
  • INTS N/A
  • WVVI N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • WVVI Beverages (Production/Distribution)
  • Sector
  • INTS Health Care
  • WVVI Consumer Staples
  • Exchange
  • INTS Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • INTS 30.8M
  • WVVI 29.0M
  • IPO Year
  • INTS 2023
  • WVVI N/A
  • Fundamental
  • Price
  • INTS $1.30
  • WVVI $6.03
  • Analyst Decision
  • INTS Strong Buy
  • WVVI
  • Analyst Count
  • INTS 3
  • WVVI 0
  • Target Price
  • INTS $8.50
  • WVVI N/A
  • AVG Volume (30 Days)
  • INTS 37.8K
  • WVVI 3.9K
  • Earning Date
  • INTS 05-08-2025
  • WVVI 05-12-2025
  • Dividend Yield
  • INTS N/A
  • WVVI N/A
  • EPS Growth
  • INTS N/A
  • WVVI N/A
  • EPS
  • INTS N/A
  • WVVI N/A
  • Revenue
  • INTS N/A
  • WVVI $39,782,442.00
  • Revenue This Year
  • INTS N/A
  • WVVI N/A
  • Revenue Next Year
  • INTS N/A
  • WVVI N/A
  • P/E Ratio
  • INTS N/A
  • WVVI N/A
  • Revenue Growth
  • INTS N/A
  • WVVI 1.65
  • 52 Week Low
  • INTS $1.27
  • WVVI $3.17
  • 52 Week High
  • INTS $5.28
  • WVVI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • INTS 22.77
  • WVVI 51.90
  • Support Level
  • INTS $1.78
  • WVVI $5.59
  • Resistance Level
  • INTS $1.94
  • WVVI $6.15
  • Average True Range (ATR)
  • INTS 0.17
  • WVVI 0.15
  • MACD
  • INTS -0.03
  • WVVI 0.00
  • Stochastic Oscillator
  • INTS 4.10
  • WVVI 66.65

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: